ASCI / Young Physician-Scientist Awards, 2024

The Young Physician-Scientist Awards (YPSA) recognize physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.

View all ASCI awards

Lauren A. Henderson, MD, MMSc
Harvard Medical School, Boston Children's Hospital
(Affiliation at the time of recognition)

About the awardee

Lauren A. Henderson, MD, MMSc is a pediatric rheumatologist at Boston Children’s Hospital and Assistant Professor of Pediatrics at Harvard Medical School. Her laboratory focuses on the role of T cells in autoimmune responses. During her K08 Award, she showed that regulatory (Treg) cells in children with systemic juvenile idiopathic arthritis (sJIA) adopt a Th17 phenotype that is abrogated with IL-1 inhibition (JCI Insight, 2020). This work supports the hypothesis that IL-1 excess in early sJIA predisposes development of chronic, Th17-mediated arthritis. As Dr. Henderson transitioned to independence, she focused on T cell responses in the joints of children with oligoarticular JIA. Her laboratory identified clonally expanded T peripheral helper (Tph) cells that are enriched in the joints of oligo JIA patients with antinuclear antibodies (ANA) and over express factors associated with B cell help. These findings indicate that ANA-positive JIA is driven by dysregulated T cell-B cell interactions, resulting in senior authorships in JCI Insight (2021) and Frontiers Immunol (2022).

During the COVID19 pandemic, Dr. Henderson cared for children with multisystem inflammatory syndrome (MIS-C). She was a co-first author on a manuscript describing the immunologic features of MIS-C (JCI, 2020), characterized antigen-specific T cells in MIS-C (senior authorship, Clin Immunol, 2022), and identified an inflammatory signature in circulating Tregs from MIS-C patients (co-author, JCI 2022). She lead the American College of Rheumatology’s Task Force on MIS-C (Arthritis Rheumatol, 2020-2022) and serve on the NIH COVID19 Guidelines Panel.